1
|
Santos NP, Colaço AA, Oliveira PA. Animal models as a tool in hepatocellular carcinoma research: A Review. Tumour Biol 2017; 39:1010428317695923. [PMID: 28347231 DOI: 10.1177/1010428317695923] [Citation(s) in RCA: 76] [Impact Index Per Article: 10.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023] Open
Abstract
Cancer is the first cause of death in developed countries and the second in developing countries. Concerning the most frequent worldwide-diagnosed cancer, primary liver cancer represents approximately 4% of all new cancer cases diagnosed globally. However, among primary liver cancer, hepatocellular carcinoma is by far the most common histological subtype. Notwithstanding the health promotion and disease prevention campaigns, more than half a million new hepatocellular carcinoma cases are reported yearly, being estimated to growth continuously until 2020. Taking this scenario under consideration and the fact that some aspects concerning hepatocellular carcinoma evolution and metastasize process are still unknown, animal models assume a crucial role to understand this disease. The animal models have also provided the opportunity to screen new therapeutic strategies. The present review was supported on research and review papers aiming the complexity and often neglected chemically induced animal models in hepatocarcinogenesis research. Despite the ongoing debate, chemically induced animal models, namely, mice and rat, can provide unique valuable information on the biotransformation mechanisms against xenobiotics and apprehend the deleterious effects on DNA and cell proteins leading to carcinogenic development. In addition, taking under consideration that no model achieves all hepatocellular carcinoma research purposes, criteria to define the " ideal" animal model, depending on the researchers' approach, are also discussed in this review.
Collapse
Affiliation(s)
- Nuno Paula Santos
- 1 Department of Veterinary Sciences, Veterinary and Animal Science Research Center (CECAV), University of Trás-os-Montes and Alto Douro (UTAD), Vila Real, Portugal.,2 Center for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), University of Trás-os-Montes and Alto Douro (UTAD), Vila Real, Portugal
| | - Aura Antunes Colaço
- 1 Department of Veterinary Sciences, Veterinary and Animal Science Research Center (CECAV), University of Trás-os-Montes and Alto Douro (UTAD), Vila Real, Portugal
| | - Paula Alexandra Oliveira
- 1 Department of Veterinary Sciences, Veterinary and Animal Science Research Center (CECAV), University of Trás-os-Montes and Alto Douro (UTAD), Vila Real, Portugal.,2 Center for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), University of Trás-os-Montes and Alto Douro (UTAD), Vila Real, Portugal
| |
Collapse
|
2
|
Riccio EKP, Pratt-Riccio LR, Bianco-Júnior C, Sanchez V, Totino PRR, Carvalho LJM, Daniel-Ribeiro CT. Molecular and immunological tools for the evaluation of the cellular immune response in the neotropical monkey Saimiri sciureus, a non-human primate model for malaria research. Malar J 2015; 14:166. [PMID: 25927834 PMCID: PMC4416248 DOI: 10.1186/s12936-015-0688-1] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2014] [Accepted: 04/10/2015] [Indexed: 02/07/2023] Open
Abstract
Background The neotropical, non-human primates (NHP) of the genus Saimiri and Aotus are recommended by the World Health Organization as experimental models for the study of human malaria because these animals can be infected with the same Plasmodium that cause malaria in humans. However, one limitation is the lack of immunological tools to assess the immune response in these models. The present study focuses on the development and comparative use of molecular and immunological methods to evaluate the cellular immune response in Saimiri sciureus. Methods Blood samples were obtained from nineteen uninfected Saimiri. Peripheral blood mononuclear cells (PBMC) from these animals and splenocytes from one splenectomized animal were cultured for 6, 12, 18, 24, 48, 72 and 96 hrs in the presence of phorbol-12-myristate-13-acetate and ionomycin. The cytokine levels in the supernatant were detected using human and NHP cytometric bead array Th1/Th2 cytokine kits, the Bio-Plex Pro Human Cytokine Th1/Th2 Assay, enzyme-linked immunosorbent assay, enzyme-linked immunospot assays and intracellular cytokine secretion assays. Cytokine gene expression was examined through TaqMan® Gene Expression Real-Time PCR using predesigned human gene-specific primers and probes or primers and probes designed based on published S. sciureus cytokine sequences. Results The use of five assays based on monoclonal antibodies specific for human cytokines facilitated the detection of IL-2, IL-4 and/or IFN-γ. TaqMan array plates facilitated the detection of 12 of the 28 cytokines assayed. However, only seven cytokines (IL-1A, IL-2, IL-10, IL-12B, IL-17, IFN-β, and TNF) presented relative expression levels of at least 70% of the gene expression observed in human PBMC. The use of primers and probes specific for S. sciureus cytokines facilitated the detection of transcripts that showed relative expression below the threshold of 70%. The most efficient evaluation of cytokine gene expression, in PBMC and splenocytes, was observed after 6–12 hrs of culture, except for LTA in PBMC, whose expression was best analysed after 24 hrs of culture. Conclusions Real-time PCR facilitates the analysis of a large number of cytokines altered during malaria infection, and this technique is considered the best tool for the evaluation of the cellular immune response in S. sciureus.
Collapse
Affiliation(s)
- Evelyn K P Riccio
- Laboratório de Pesquisa em Malária, Instituto Oswaldo Cruz, Fiocruz, Avenida Brasil 4365, Pavilhão Leônidas Deane, Salas 513-517, 5° andar Manguinhos, Rio de Janeiro, RJ, CEP: 21040-900, Brazil. .,Centro de Pesquisa, Diagnóstico e Treinamento em Malária (CPD-Mal), Fiocruz, Reference Centre for Malaria in the Extra-Amazonian Region for the Secretary for Health Surveillance, Ministry of Health, Rio de Janeiro, RJ, Brazil.
| | - Lilian R Pratt-Riccio
- Laboratório de Pesquisa em Malária, Instituto Oswaldo Cruz, Fiocruz, Avenida Brasil 4365, Pavilhão Leônidas Deane, Salas 513-517, 5° andar Manguinhos, Rio de Janeiro, RJ, CEP: 21040-900, Brazil. .,Centro de Pesquisa, Diagnóstico e Treinamento em Malária (CPD-Mal), Fiocruz, Reference Centre for Malaria in the Extra-Amazonian Region for the Secretary for Health Surveillance, Ministry of Health, Rio de Janeiro, RJ, Brazil.
| | - Cesare Bianco-Júnior
- Laboratório de Pesquisa em Malária, Instituto Oswaldo Cruz, Fiocruz, Avenida Brasil 4365, Pavilhão Leônidas Deane, Salas 513-517, 5° andar Manguinhos, Rio de Janeiro, RJ, CEP: 21040-900, Brazil. .,Centro de Pesquisa, Diagnóstico e Treinamento em Malária (CPD-Mal), Fiocruz, Reference Centre for Malaria in the Extra-Amazonian Region for the Secretary for Health Surveillance, Ministry of Health, Rio de Janeiro, RJ, Brazil.
| | - Violette Sanchez
- Laboratório de Pesquisa em Malária, Instituto Oswaldo Cruz, Fiocruz, Avenida Brasil 4365, Pavilhão Leônidas Deane, Salas 513-517, 5° andar Manguinhos, Rio de Janeiro, RJ, CEP: 21040-900, Brazil. .,Centro de Pesquisa, Diagnóstico e Treinamento em Malária (CPD-Mal), Fiocruz, Reference Centre for Malaria in the Extra-Amazonian Region for the Secretary for Health Surveillance, Ministry of Health, Rio de Janeiro, RJ, Brazil. .,Present address: Research Department, Sanofi Pasteur, Lyon, France.
| | - Paulo R R Totino
- Laboratório de Pesquisa em Malária, Instituto Oswaldo Cruz, Fiocruz, Avenida Brasil 4365, Pavilhão Leônidas Deane, Salas 513-517, 5° andar Manguinhos, Rio de Janeiro, RJ, CEP: 21040-900, Brazil. .,Centro de Pesquisa, Diagnóstico e Treinamento em Malária (CPD-Mal), Fiocruz, Reference Centre for Malaria in the Extra-Amazonian Region for the Secretary for Health Surveillance, Ministry of Health, Rio de Janeiro, RJ, Brazil.
| | - Leonardo J M Carvalho
- Laboratório de Pesquisa em Malária, Instituto Oswaldo Cruz, Fiocruz, Avenida Brasil 4365, Pavilhão Leônidas Deane, Salas 513-517, 5° andar Manguinhos, Rio de Janeiro, RJ, CEP: 21040-900, Brazil. .,Centro de Pesquisa, Diagnóstico e Treinamento em Malária (CPD-Mal), Fiocruz, Reference Centre for Malaria in the Extra-Amazonian Region for the Secretary for Health Surveillance, Ministry of Health, Rio de Janeiro, RJ, Brazil.
| | - Cláudio Tadeu Daniel-Ribeiro
- Laboratório de Pesquisa em Malária, Instituto Oswaldo Cruz, Fiocruz, Avenida Brasil 4365, Pavilhão Leônidas Deane, Salas 513-517, 5° andar Manguinhos, Rio de Janeiro, RJ, CEP: 21040-900, Brazil. .,Centro de Pesquisa, Diagnóstico e Treinamento em Malária (CPD-Mal), Fiocruz, Reference Centre for Malaria in the Extra-Amazonian Region for the Secretary for Health Surveillance, Ministry of Health, Rio de Janeiro, RJ, Brazil.
| |
Collapse
|
4
|
Xu Y, Qi W, Wang X, Zhao P, Zhang Y, Zhang Q, Qin S, Wang J. Pegylated interferon α-2a plus ribavirin for decompensated hepatitis C virus-related cirrhosis: relationship between efficacy and cumulative dose. Liver Int 2014; 34:1522-31. [PMID: 25453135 DOI: 10.1111/liv.12417] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Abstract
BACKGROUND & AIMS A combination of pegylated interferon alpha-2a (Peg-IFNα-2a) and ribavirin (RBV) achieves a sustained virological response (SVR) in 40-50% of patients infected with genotype 1 hepatitis C virus (HCV), but efficacy rates are significantly lower in patients with decompensated HCV-induced cirrhosis. The efficacy and tolerability of Peg-IFNα-2a and RBV, the cumulative dose effect, time to achieve planned cumulative dose and role of HCV phenotype on treatment response were determined in patients with decompensated HCV-induced cirrhosis. METHODS In this case-controlled study, 257 patients with decompensated HCV-induced cirrhosis were enrolled, including patients treated with partial splenic embolization for leukopaenia. Of patients with sufficient blood cell counts, 130 patients opted for antiviral therapy (treatment group) consisting of 180 μg/kg Peg-IFNα-2a for 48 weeks with 800-1200 mg/day RBV; the remaining 127 were considered the control group. Primary endpoints were SVR and absence of relapse; the secondary end point was assessment of disease progression. RESULTS Sustained virological response was highest and relapse rates were lowest when cumulative doses of Peg-IFNα-2a and RBV were both ≥80% of the prescribed dose. Patients achieving ≥80% of the planned cumulative doses in 48 weeks had a significantly higher SVR compared with patients achieving this in 72 weeks. Patients with HCV genotype 1 had significantly lower SVR compared with patients with HCV genotype 2 (19.7% vs. 42.9%, respectively; P = 0.008). Treatment group patients had a significantly lower rate of SVR-independent liver disease-related mortality. CONCLUSIONS Our findings provide additional evidence to support the use of Peg-IFNα-2a and RBV therapy for decompensated HCV-induced cirrhosis.
Collapse
Affiliation(s)
- Yan Xu
- Department of Digestive; China-Japan Union Hospital affiliated to Jilin University; Changchun China
| | - Wenqian Qi
- Department of Digestive; China-Japan Union Hospital affiliated to Jilin University; Changchun China
| | - Xu Wang
- Department of Digestive; China-Japan Union Hospital affiliated to Jilin University; Changchun China
| | - Ping Zhao
- Department of Digestive; China-Japan Union Hospital affiliated to Jilin University; Changchun China
| | - Yonggui Zhang
- Department of Digestive; China-Japan Union Hospital affiliated to Jilin University; Changchun China
| | - Qian Zhang
- Department of Digestive; China-Japan Union Hospital affiliated to Jilin University; Changchun China
| | - Shaoyou Qin
- Department of Digestive; China-Japan Union Hospital affiliated to Jilin University; Changchun China
| | - Jiangbin Wang
- Department of Digestive; China-Japan Union Hospital affiliated to Jilin University; Changchun China
| |
Collapse
|